Log In
Print this Print this

DSP Arotinolol Hydrochloride, arotinolol (formerly Almarl)

  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionMixed alpha and beta blocker
Molecular Target Adrenergic receptor beta 2 (ADRB2) ; Adrenergic receptor alpha 1 (ADRA1)
Mechanism of ActionAdrenergic receptor alpha 1 (ADRA1) antagonist; Adrenergic receptor beta 2 (ADRB2) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today